Skip to main content
Figure 6 | Molecular Cancer

Figure 6

From: Sodium glucose cotransporter 1 ligand BLF501 as a novel tool for management of gastrointestinal mucositis

Figure 6

Tumor growth rate and weight in mice treated with chemotherapy alone or in conjunction with BLF501. Oral administration of BLF501 did not interfere with the antitumor activity of DXR. DXR-treated mice showed a reduction of body weight at the end of experiment, while a slight weight increase was observed in mice treated with DXR and BLF501. Error bars means SD Experiments were performed in triplicate.

Back to article page

Molecular Cancer

ISSN: 1476-4598